{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:13:59Z","timestamp":1773076439509,"version":"3.50.1"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,11,30]]},"DOI":"10.1248\/bpb.b24-00610","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T22:13:45Z","timestamp":1732918425000},"page":"1961-1968","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Meroterpenoids from &lt;i&gt;Sargassum macrocarpum&lt;\/i&gt; on the Inhibition of Amyloid Polypeptide Aggregation"],"prefix":"10.1248","volume":"47","author":[{"given":"Yuta","family":"Tozawa","sequence":"first","affiliation":[{"name":"Graduate School of Science and Technology, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Shinoda","sequence":"additional","affiliation":[{"name":"Faculty of Bioresources and Environmental Science, Ishikawa Prefectural University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Faculty of Bioresources and Environmental Science, Ishikawa Prefectural University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusaku","family":"Miyamae","sequence":"additional","affiliation":[{"name":"Institute of Life and Environmental Sciences, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Shigemori","sequence":"additional","affiliation":[{"name":"Institute of Life and Environmental Sciences, University of Tsukuba"},{"name":"Microbiology Research Center for Sustainability (MiCS), University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hamz\u00e9 R, Delangre E, Tolu S, Moreau M, Janel N, Bailb\u00e9 D, Movassat J. Type 2 diabetes mellitus and Alzheimer\u2019s disease: shared molecular mechanisms and potential common therapeutic targets. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 15287 (2022).","DOI":"10.3390\/ijms232315287"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. <i>Neurology<\/i>, <b>53<\/b>, 1937\u20131942 (1999).","DOI":"10.1212\/WNL.53.9.1937"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu J, Wands JR, de la Monte SM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? <i>J. Alzheimers Dis.<\/i>, <b>7<\/b>, 63\u201380 (2005).","DOI":"10.3233\/JAD-2005-7107"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) de la Monte SM, Wands JR. Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed. <i>J. Diabetes Sci. Technol.<\/i>, <b>2<\/b>, 1101\u20131113 (2008).","DOI":"10.1177\/193229680800200619"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. <i>Acta Neuropathol.<\/i>, <b>120<\/b>, 185\u2013193 (2010).","DOI":"10.1007\/s00401-010-0690-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cooper GJ, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KB. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>85<\/b>, 7763\u20137766 (1988).","DOI":"10.1073\/pnas.85.20.7763"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Toyama BH, Weissman JS. Amyloid structure: Conformational diversity and consequences. <i>Annu. Rev. Biochem.<\/i>, <b>80<\/b>, 557\u2013585 (2011).","DOI":"10.1146\/annurev-biochem-090908-120656"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ono K. Alzheimer\u2019s disease as oligomeropathy. <i>Neurochem. Int.<\/i>, <b>119<\/b>, 57\u201370 (2018).","DOI":"10.1016\/j.neuint.2017.08.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Haass C, Selkoe D. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>8<\/b>, 101\u2013112 (2007).","DOI":"10.1038\/nrm2101"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. <i>J. Biol. Chem.<\/i>, <b>280<\/b>, 17294\u201317300 (2005).","DOI":"10.1074\/jbc.M500997200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Smith LM, Strittmatter SM. Binding sites for amyloid-\u03b2 oligomers and synaptic toxicity. <i>Cold Spring Harb. Perspect. Med.<\/i>, <b>7<\/b>, a024075 (2017).","DOI":"10.1101\/cshperspect.a024075"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F. Amylin deposition in the brain: a second amyloid in Alzheimer disease? <i>Ann. Neurol.<\/i>, <b>74<\/b>, 517\u2013526 (2013).","DOI":"10.1002\/ana.23956"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, L\u00e0szl\u00f3 F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. <i>Neurobiol. Aging<\/i>, <b>31<\/b>, 1503\u20131515 (2010).","DOI":"10.1016\/j.neurobiolaging.2008.08.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hmidene AB, Hanaki M, Murakami K, Irie K, Isoda H, Shigemori H. Inhibitory activities of antioxidant flavonoids from <i>Tamarix gallica<\/i> on amyloid aggregation related to Alzheimer\u2019s and Type 2 diabetes diseases. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 238\u2013241 (2017).","DOI":"10.1248\/bpb.b16-00801"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ren B, Liu Y, Zhang Y, Cai Y, Gong X, Chang Y, Xu L, Zheng J. Genistein: a dual inhibitor of both amyloid \u03b2 and human islet amylin peptides. <i>ACS Chem. Neurosci.<\/i>, <b>9<\/b>, 1215\u20131224 (2018).","DOI":"10.1021\/acschemneuro.8b00039"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Doytchinova I, Atanasova M, Salamanova E, Ivanov S, Dimitrov I. Curcumin inhibits the primary nucleation of amyloid-beta peptide: a molecular dynamics study. <i>Biomolecules<\/i>, <b>10<\/b>, 1323 (2020).","DOI":"10.3390\/biom10091323"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kamei Y, Sueyoshi M, Hayashi K, Terada R, Nozaki H. The novel anti-propionibacterium acnes compound, Sargafuran, found in the marine brown alga <i>Sargassum macrocarpum.<\/i> <i>J. Antibiot.<\/i> (Tokyo), <b>62<\/b>, 259\u2013263 (2009).","DOI":"10.1038\/ja.2009.25"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Shinoda S, Tozawa Y, Kurimoto S, Shigemori H, Sekiguchi M. Three new meroterpenoids from <i>Sargassum macrocarpum<\/i> and their inhibitory activity against amyloid \u03b2 aggregation. <i>J. Nat. Med.<\/i>, <b>77<\/b>, 508\u2013515 (2023).","DOI":"10.1007\/s11418-023-01693-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Naiki H, Gejyo F. Kinetic analytics of amyloid fibril formation. <i>Methods Enzymol.<\/i>, <b>309<\/b>, 305\u2013318 (1999).","DOI":"10.1016\/S0076-6879(99)09022-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sun J, Jiang G, Shigemori H. Inhibitory activity on amyloid aggregation of rosmarinic acid and its substructures from <i>Isodon japonicus.<\/i> <i>Nat. Prod. Commun.<\/i>, <b>14<\/b>, 1\u20135 (2019).","DOI":"10.1177\/1934578X19843039"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils <i>in vitro.<\/i> <i>J. Neurosci. Res.<\/i>, <b>75<\/b>, 742\u2013750 (2004).","DOI":"10.1002\/jnr.20025"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mirhashemi SM, Aarabi MH. Effect of two herbal polyphenol compounds on human amylin amyloid formation and destabilization. <i>J. Med. Plants Res.<\/i>, <b>6<\/b>, 3207\u20133212 (2012).","DOI":"10.5897\/JMPR11.1789"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bitan G, Teplow DB. Rapid photochemical cross-linking\u2014a new tool for studies of metastable, amyloidogenic protein assemblies. <i>Acc. Chem. Res.<\/i>, <b>37<\/b>, 357\u2013364 (2004).","DOI":"10.1021\/ar000214l"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rahimi F, Maiti P, Bitan G. Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. <i>J. Vis. Exp.<\/i>, <b>23<\/b>, 1071 (2009).","DOI":"10.3791\/1071"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Murakami K, Irie K. Three structural features of functional food components and herbal medicine with amyloid \u03b242 anti-aggregation properties. <i>Molecules<\/i>, <b>24<\/b>, 2125 (2019).","DOI":"10.3390\/molecules24112125"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>100<\/b>, 330\u2013335 (2003).","DOI":"10.1073\/pnas.222681699"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Bitan G, Fradinger EA, Spring SM, Teplow DB. Neurotoxic protein oligomers\u2009\u2014\u2009what you see is not always what you get. <i>Amyloid<\/i>, <b>12<\/b>, 88\u201395 (2005).","DOI":"10.1080\/13506120500106958"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Velander P, Wu L, Hildreth SB, Vogelaar NJ, Mukhopadhyay B, Helm RF, Zhang S, Xu B. Catechol-containing compounds are a broad class of protein aggregation inhibitors: redox state is a key determinant of the inhibitory activities. <i>Pharmacol. Res.<\/i>, <b>184<\/b>, 106409 (2022).","DOI":"10.1016\/j.phrs.2022.106409"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ibrahim NF, Hamezah HS, Yanagisawa D, Tsuji M, Kiuchi Y, Ono K, Tooyama I. The effect of \u03b1-tocopherol, \u03b1- and \u03b3-tocotrienols on amyloid-\u03b2 aggregation and disaggregation <i>in vitro.<\/i> <i>Biochem. Biophys. Rep.<\/i>, <b>28<\/b>, 101131 (2021).","DOI":"10.1016\/j.bbrep.2021.101131"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kurisu M, Miyamae Y, Murakami K, Han J, Isoda H, Irie K, Shigemori H. Inhibition of amyloid \u03b2 aggregation by acteoside, a phenylethanoid glycoside. <i>Biosci. Biotechnol. Biochem.<\/i>, <b>77<\/b>, 1329\u20131332 (2013).","DOI":"10.1271\/bbb.130101"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tsunoda T, Takase M, Shigemori H. Structure\u2013activity relationship of clovamide and its related compounds for the inhibition of amyloid \u03b2 aggregation. <i>Bioorg. Med. Chem.<\/i>, <b>26<\/b>, 3202\u20133209 (2018).","DOI":"10.1016\/j.bmc.2018.04.044"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nomoto D, Tsunoda T, Shigemori H. Effects of clovamide and its related compounds on the aggregations of amyloid polypeptides. <i>J. Nat. Med.<\/i>, <b>75<\/b>, 299\u2013307 (2021).","DOI":"10.1007\/s11418-020-01467-w"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Tanaka T, Betkekar VV, Ohmori K, Suzuki K, Shigemori H. Evaluation of amyloid polypeptide aggregation inhibition and disaggregation activity of A-type procyanidins. <i>Pharmaceuticals<\/i> (Basel), <b>14<\/b>, 1118 (2021).","DOI":"10.3390\/ph14111118"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Sampei T, Wu Y, Shigemori H. Amyloid polypeptide disaggregation activity of passion fruit seed-derived polyphenol compounds. <i>Nat. Prod. Commun.<\/i>, <b>17<\/b>, 1934578X221092710 (2022).","DOI":"10.1177\/1934578X221092710"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Basagni F, Naldi M, Ginex T, Luque FJ, Fagiani F, Lanni C, Iurlo M, Marcaccio M, Minarini A, Bartolini M, Rosini M. Inhibition of \u03b2-amyloid aggregation in Alzheimer\u2019s disease: the key role of (pro)electrophilic warheads. <i>ACS Med. Chem. Lett.<\/i>, <b>13<\/b>, 1812\u20131818 (2022).","DOI":"10.1021\/acsmedchemlett.2c00410"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/11\/47_b24-00610\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:28:49Z","timestamp":1732937329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/11\/47_b24-00610\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00610","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"article-number":"b24-00610"}}